Are medical comorbid conditions of bipolar disorder due to immune dysfunction?

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials

(2014) Farhad Faridhosseini et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder

(2014) Johan Söderlund et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Diabetes Mellitus and Disturbances in Brain Connectivity: A Bidirectional Relationship?

(2014) Rodrigo B. Mansur et al.   NEUROMOLECULAR MEDICINE

Rheumatoid Arthritis and the Risk of Bipolar Disorder: A Nationwide Population-Based Study

(2014) Chih-Chao Hsu et al.   PLoS One

Inflamed moods: A review of the interactions between inflammation and mood disorders

(2014) Joshua D. Rosenblat et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects

(2014) Ole Köhler et al.   JAMA Psychiatry

Physical health of patients with bipolar disorder

(2013) A. H. Young et al.   ACTA PSYCHIATRICA SCANDINAVICA

Obesity and Bipolar Disorder: Synergistic Neurotoxic Effects?

(2013) Celina S. Liu et al.   ADVANCES IN THERAPY

Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators

(2013) Davy Vancampfort et al.   AMERICAN JOURNAL OF PSYCHIATRY

CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS

(2013) Andrew H. Miller et al.   DEPRESSION AND ANXIETY

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

(2013) J.C. Felger et al.   NEUROSCIENCE

Proinflammation: the key to arterial aging

(2013) Mingyi Wang et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Neuroinflammatory basis of metabolic syndrome

(2013) Sudarshana Purkayastha et al.   Molecular Metabolism

Novel therapeutic targets in depression: Minocycline as a candidate treatment

(2012) Joanna K. Soczynska et al.   BEHAVIOURAL BRAIN RESEARCH

Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder

(2012) Sara K Olsson et al.   BIPOLAR DISORDERS

Is bipolar disorder an inflammatory condition? The relevance of microglial activation

(2012) Laura Stertz et al.   CURRENT OPINION IN PSYCHIATRY

Chemokines in bipolar disorder: Trait or state?

(2012) Izabela Guimarães Barbosa et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

(2012) Robert K McNamara et al.   Expert Review of Neurotherapeutics

Cardiovascular Disease and Bipolar Disorder

(2012) Holly A. Swartz et al.   JOURNAL OF CLINICAL PSYCHIATRY

Interferon-Induced Depression in Chronic Hepatitis C

(2012) Marc Udina et al.   JOURNAL OF CLINICAL PSYCHIATRY

Microglia in the developing brain: A potential target with lifetime effects

(2012) G. Jean Harry et al.   NEUROTOXICOLOGY

Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample

(2012) Manuel Gurpegui et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Obesity in Bipolar Disorder: An Overview

(2012) Susan L. McElroy et al.   Current Psychiatry Reports

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Microglial Activation – Tuning and Pruning Adult Neurogenesis

(2012) Christine T. Ekdahl   Frontiers in Pharmacology

Atypical Antipsychotic-Induced Weight Gain

(2011) James L. Roerig et al.   CNS DRUGS

Refractoriness in Bipolar Disorder: Definitions and Evidence-Based Treatment

(2011) Konstantinos N. Fountoulakis   CNS Neuroscience & Therapeutics

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

(2011) Lev Gertsik et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection

(2011) Maryam Alavi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Dose-Dependent Effects of Endotoxin on Neurobehavioral Functions in Humans

(2011) Jan-Sebastian Grigoleit et al.   PLoS One

Autoimmune diseases, bipolar disorder, and non-affective psychosis

(2010) William W Eaton et al.   BIPOLAR DISORDERS

Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction

(2010) Keigan M. Park et al.   CELLULAR SIGNALLING

Bipolar disorder and metabolic syndrome: An international perspective

(2010) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus

(2010) Joanna K. Soczynska et al.   NEUROMOLECULAR MEDICINE

Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus

(2009) Elizabeth A. Bachen et al.   ARTHRITIS AND RHEUMATISM

Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity

(2009) Neil A. Harrison et al.   BIOLOGICAL PSYCHIATRY

Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity

(2009) Daniel Lindqvist et al.   BIOLOGICAL PSYCHIATRY

Can body mass index help predict outcome in patients with bipolar disorder?

(2009) Cynthia Calkin et al.   BIPOLAR DISORDERS

Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder

(2009) Elisa Brietzke et al.   BRAIN BEHAVIOR AND IMMUNITY

Reduced mania and depression in juvenile bipolar disorder associated with long-chain ω-3 polyunsaturated fatty acid supplementation

(2009) E H Clayton et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

(2009) Elisa Brietzke et al.   JOURNAL OF AFFECTIVE DISORDERS

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder

(2009) Benjamin I. Goldstein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

(2009) J S Rao et al.   MOLECULAR PSYCHIATRY

Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder

(2008) Shima Jazayeri et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study

(2008) Fabiano G. Nery et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway

(2008) R R Girgis et al.   MOLECULAR PSYCHIATRY

The relationship between the fatty acid composition of immune cells and their function

(2008) Philip C. Calder   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

From inflammation to sickness and depression: when the immune system subjugates the brain

(2007) Robert Dantzer et al.   NATURE REVIEWS NEUROSCIENCE

Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex

(2003) Yarema B. Bezchlibnyk et al.   JOURNAL OF NEUROCHEMISTRY